Intuitive Surgical reported better-than-expected third-quarter earnings and revenue, propelled by increasing global demand for its robotic systems used in minimally invasive procedures. Following the announcement, shares of the Sunnyvale, California-based company surged 17% in extended trading.
The company, best known for its da Vinci robotic surgical systems, continues to experience strong growth as hospitals address a backlog of postponed surgeries and broaden access to robotic-assisted, minimally invasive care.
Intuitive Surgical also raised its adjusted gross profit margin forecast for 2025 to a range of 67% to 67.5%, up from the earlier projection of 66% to 67%. The revised forecast accounts for an estimated tariff impact of 0.7% of revenue, plus or minus 10 basis points, compared to the previously estimated 1% impact.
More than 80% of the instruments and accessories used in the da Vinci system are manufactured at the company’s facility in Mexico, with additional operations in China and other international markets.
The company now expects worldwide da Vinci-assisted procedures to grow by 17% to 17.5% in 2025, up from the previous range of 15.5% to 17%, reflecting robust adoption and clinical demand.
For the quarter ended September 30, Intuitive Surgical reported adjusted earnings of $2.40 per share, exceeding analysts’ estimates of $1.98 per share, according to LSEG data. The company’s revenue reached $2.51 billion, surpassing expectations of $2.40 billion for the third quarter.
The strong quarterly performance underscores the company’s leadership in robotic-assisted surgery and highlights continued global expansion of minimally invasive surgical care.
Also Read